MARKET

MTP

MTP

Midatech Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.890
+0.020
+1.07%
After Hours: 1.915 +0.025 +1.32% 16:03 07/30 EDT
OPEN
1.880
PREV CLOSE
1.870
HIGH
1.910
LOW
1.850
VOLUME
94.93K
TURNOVER
--
52 WEEK HIGH
4.330
52 WEEK LOW
1.600
MARKET CAP
37.22M
P/E (TTM)
-0.5338
1D
5D
1M
3M
1Y
5Y
Midatech Pharma PLC Announces Appointment of Chief Scientific Officer
Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific OfficerABINGDON, OXFORDSHIRE / ACCESSWIRE / July 12, 2021 / Midatech Pharma PLC (AIM:MTPH; Nasdaq:MTP), a ...
ACCESSWIRE · 07/12 13:50
Midatech Pharma Appoints New Chief Scientific Officer
marketwatch.com · 07/12 13:40
Midatech Pharma Secures £10M In Equity To Fund Product Development
Benzinga · 06/29 13:01
Midatech Pharma Announced UK Offering of 35M Shares Priced @ £0.285/Placing Share
Midatech Pharma PLC (Nasdaq: MTP) announces that it has raised £10.0 million (before expenses) by way of a placing to investors in the UK ("Placing") of 35,087,720 new ordinary shares of 0.1p each ("Placing Shares") at an issue price of £0.285 per Placing ...
Benzinga · 06/29 09:29
48 Biggest Movers From Yesterday
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.
Benzinga · 06/22 09:13
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 06/21 16:39
50 Biggest Movers From Yesterday
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share.
Benzinga · 06/18 09:03
Midatech reaches a four-month high as webinar highlights Q-Sphera platform
sefa ozel/E+ via Getty Images The nano-cap biotech company, Midatech Pharma ([[MTP]] +35.8%) looks set to record its biggest one-day gain in more than four months and reach the highest
Seekingalpha · 06/17 17:14
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MTP. Analyze the recent business situations of Midatech Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.25%
Pharmaceuticals & Medical Research
-0.38%
Key Executives
Non-Executive Chairman
Rolf Stahel
Chief Executive Officer/Chief Financial Officer/Director
Stephen Stamp
Chief Scientific Officer
Daniel Palmer
Other
Justin Barry
Other
Tim Sparey
Non-Executive Director
Simon De Vries
Non-Executive Independent Director
Simon Turton
No Data
About MTP
Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTP stock methods without spending real money on the virtual paper trading platform.